Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?
Hepatobiliary Surg Nutr
.
2019 Aug;8(4):423-425.
doi: 10.21037/hbsn.2019.03.19.
Authors
Masahiro Ogawa
1
,
Tatsuo Kanda
1
,
Mitsuhiko Moriyama
1
Affiliation
1
Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
PMID:
31489321
PMCID:
PMC6700000
DOI:
10.21037/hbsn.2019.03.19
No abstract available
Publication types
Editorial
Comment